Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.510
-0.050 (-1.10%)
Apr 23, 2026, 2:14 PM EDT - Market open
Camp4 Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$8.60
Upside
+90.69%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +55.21% | Apr 14, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +99.56% | Apr 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $7 | Buy | Initiates | $7 | +55.21% | Oct 2, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 16, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 → $12 | Buy | Maintains | $18 → $12 | +166.08% | Sep 15, 2025 |
| Wedbush | Wedbush | Buy Initiates $8 | Buy | Initiates | $8 | +77.38% | May 27, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $17 | Buy | Initiates | $17 | +276.94% | Nov 5, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $23 | Buy | Initiates | $23 | +409.98% | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $18 | Buy | Initiates | $18 | +299.11% | Nov 5, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $8.05 → $6.9 | Strong Sell | Maintains | $8.05 → $6.9 | +52.99% | Jan 11, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $18 → $8.05 | Strong Sell | Maintains | $18 → $8.05 | +78.49% | Oct 9, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | +154.99% | Oct 6, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $138 → $115 | Strong Buy | Maintains | $138 → $115 | +2,449.89% | Oct 6, 2023 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $138 | Strong Buy | Reiterates | $138 | +2,959.87% | Aug 29, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $63 → $18 | Strong Sell | Maintains | $63 → $18 | +307.98% | Jul 13, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.